AIDS Home > Reyataz and Pregnancy
According to animal studies on Reyataz and pregnancy, the medication is probably safe for pregnant women. It is important to realize, however, that animals do not always respond to medicines the same way as humans. Healthcare providers should only prescribe Reyataz to pregnant women if the benefits outweigh any possible risks. If you are taking Reyataz and pregnancy occurs, notify your healthcare provider immediately.
Reyataz® (atazanavir sulfate) is a prescription HIV medication. Based on information from animal studies, the drug is probably safe for use during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category B is given to medicines that have not been studied in pregnant humans but that do not appear to cause harm to the fetus in animal studies. In animal studies, Reyataz did not cause any problems when given during pregnancy.
However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category B medicine should be given to a pregnant woman only if her healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.
Your healthcare provider may need to adjust your dosage of Reyataz during pregnancy, particularly if you are taking certain other medications and you have taken other HIV medications in the past (see Reyataz Dosage for more information).
If you are pregnant or are thinking of becoming pregnant while taking Reyataz, let your healthcare provider know. He or she will consider both the benefits and risks of using the drug during pregnancy before making a recommendation in your particular situation. Be sure to seek early prenatal care, as women with HIV or AIDS need special care, both for themselves and their babies.